NCT06834594View on ClinicalTrials.gov

Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome

PHASE4RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

July 30, 2026

Study Completion Date

July 31, 2026

Conditions
Turner SyndromePrimary Ovarian Insufficiency (Poi)
Interventions
DRUG

Micronized progesterone 200 MG

Oral micronized progesterone 200mg for the first 12 days of a 30 to 31-day cycle

DRUG

Micronized Progesterone 100 MG

Oral micronized progesterone 100mg daily taken throughout the 30 to 31-day cycle.

Trial Locations (1)

64108

RECRUITING

Children's Mercy Hospital, Kansas City

All Listed Sponsors
lead

Children's Mercy Hospital Kansas City

OTHER